Investor Presentation | FY-2022

Credit quality improving with market leading coverage Impaired loans and allowances (All figures are in AED bn) 6.3 6.4 6.1 5.8 6.0 37.2 37.9 37.7 37.9 39.4 29.2 29.5 28.3 26.6 27.3 143 145 128 129 133 Q4-21 Q1-22 Q2-22 Q3-22 Q4-22 Impaired Loans (AED Bn) Impairment Allowances (AED Bn) * Coverage ratio (%) NPL Ratio (%) Coverage by Stage* * Stagewise ECL (AED bn) Key Highlights NPL ratio improved by 0.3% to 6.0% in 2022 on continued strong writebacks and recoveries • Coverage ratio strengthened 17% to 145% in 2022 - S3 coverage increased to 98.8% as writeback and recoveries reduced impaired loan balances - S1 & S2 coverage increased due to a movement in MEV assumptions 108 bps cost of risk within guidance 2023 guidance lowered to '<100bp' on recovery pipeline and higher coverage level attained by DenizBank since acquisition Total Gross Loans 37.2 39.4 1.1% Stage 1 Stage 2 1.0% 22.2% 3.8 4.8 Stage 1 FY-21 | AED 459bn 26.8% 6.9 7.8 Stage 2 Stage 1 86.8% Stage 2 6.8% Stage 3 6.3% Stage 3 90.6% 98.8% 26.4 26.8 Stage 3 FY-21 FY-22 FY-21 FY-22 Includes purchase originated credit impaired loans of AED 0.8 bn (Dec-21: AED 1bn) acquired at fair value / **Stage 3 coverage adjusted for POCI acquired at FV FY22 | AED 456bn Stage 1 87.7% Stage 2 6.4% Stage 3 6.0% 23

View entire presentation